Race-dependent association of sulfidogenic bacteria with colorectal cancer

Gut

Volumn 66, Issue 11, 2017, Pages 1983-1994

  Yazici, Cemal ^a   Wolf, Patricia G ^b   Kim, Hajwa ^c   Cross, Tzu Wen L ^b   Vermillion, Karin ^b   Carroll, Timothy ^a   Augustus, Gaius J ^d   Mutlu, Ece ^e   Tussing Humphreys, Lisa ^a   Braunschweig, Carol ^c   Xicola, Rosa M ^f   Jung, Barbara ^a   Llor, Xavier ^f   Ellis, Nathan A ^d   Gaskins, H Rex ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e RUSH UNIVERSITY MEDICAL CENTER   (United States)

^f YALE UNIVERSITY   (United States)

Author keywords

COLONIC MICROFLORA; COLORECTAL CANCER; HYDROGEN SULPHIDE

Indexed keywords

DNA 16S; FAT INTAKE; PROTEIN INTAKE;

ADULT; AFRICAN AMERICAN; ARTICLE; BACTERIUM; BILOPHILA WADSWORTHIA; CANCER RISK; CAUCASIAN; COLON BIOPSY; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DISCRIMINANT ANALYSIS; DISEASE ASSOCIATION; DNA SEQUENCE; FAT INTAKE; FEMALE; GENE SEQUENCE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN INTAKE; RACE DIFFERENCE; RISK FACTOR; SULFIDOGENIC BACTERIA; ADENOCARCINOMA; ADVERSE EFFECTS; AGED; CASE CONTROL STUDY; CLINICAL TRIAL; COLON; COLORECTAL NEOPLASMS; DIET; ETHNOLOGY; GRAM NEGATIVE ANAEROBIC BACTERIA; HEALTH DISPARITY; ILLINOIS; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGED; CASE-CONTROL STUDIES; CHICAGO; COLON; COLORECTAL NEOPLASMS; DIET; DIETARY FATS; DIETARY PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; SULFUR-REDUCING BACTERIA;

EID: 85013354757     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-313321     Document Type: Article

References (64)

1. American Cancer Society. Cancer Facts & Figures 2016. Atlanta: American Cancer Society, 2016.
2. Carethers JM. Screening for colorectal cancer in African Americans: determinants and rationale for an earlier age to commence screening. Dig Dis Sci 2015;60:711-21.
3. Cho M, Carter J, Harari S, et al. The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis. Clin Lab Med 2014;34:699-710.
4. Schulz MD, Atay C, Heringer J, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature 2014;514:508-12.
5. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14:207-15.
6. Gao Z, Guo B, Gao R, et al. Microbiota dysbiosis is associated with colorectal cancer. Front Microbiol 2015;6:20.
7. Kostic AD, Gevers D, Pedamallu CS, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012;22:292-8.
8. Warren RL, Freeman DJ, Pleasance S, et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013;1:16.
9. Wang T, Cai G, Qiu Y, et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J 2012;6:320-9.
10. Chen W, Liu F, Ling Z, et al. Human intestinal lumen and mucosa-Associated microbiota in patients with colorectal cancer. PLoS ONE 2012;7(6):e39743.
11. Castellarin M, Warren RL, Freeman JD, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012;22:299-306.
12. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014;10:766.
13. Zackular JP, Rogers MA, Ruffin MT VI, et al. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res 2014;7:1112-21.
14. OKeefe SJ, Li JV, Lahti L, et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015;6:6342.
15. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-Aminosalicyclic acid to fecal sulphide in patients with ulcerative colitis. Gut 2000;46:64-72.
16. Gibson GR, Cummings JH, Macfarlane GT. Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991;86:101-12.
17. Roediger WE, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
18. Christl SU, Eisner HD, Dusel G, et al. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: A potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci 1996;41:2477-81.
19. Deplancke B, Gaskins HR. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003;17:1310-12.
20. Attene-Ramos MS, Nava GM, Muellner MG, et al. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 2010;51:304-14.
21. Attene-Ramos MS, Wagner ED, Plewa MJ, et al. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 2006;4:9-14.
22. Attene-Ramos MS, Wagner ED, Gaskins HR, et al. Hydrogen sulfide induces direct radical-Associated DNA damage. Mol Cancer Res 2007;5:455-9.
23. Bolstad AI, Jensen HB, Bakken V. Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum. Clin Microbiol Rev 1996;9:55-71.
24. Baron EJ. Bilophila wadsworthia: A unique Gram-negative anaerobic rod. Anaerobe 1997;3:83-6.
25. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, et al. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol 2012;28:448.
26. Xicola RM, Gagnon M, Clark JR, et al. Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study. Clin Cancer Res 2014;20:4962-70.
27. Shen W, Wolf PG, Carbonero F, et al. Intestinal and systemic inflammatory responses are positively associated with sulfidogenic bacteria abundance in high-fat-fed male C57BL/6J mice. J Nutr 2014;144:1181-7.
28. Daly K, Sharp RJ, McCarthy AJ. Development of oligonucleotide probes and PCR primers for detecting phylogenetic subgroups of sulfate-reducing bacteria. Microbiol 2000;146:1693-705.
29. Klein M, Friedrich M, Roger AJ, et al. Multiple lateral transfers of dissimilatory sulfite reductase genes between major lineages of sulfate-reducing prokaryotes. J Bacteriol 2001;183:6028-35.
30. DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol 2006;72:5069-72.
31. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-Throughput community sequencing data. Nat Methods 2010;7:335-6.
32. Liu TW, Park YM, Holscher HD, et al. Physical activity differentially affects the cecal microbiota of ovariectomized female rats selectively bred for high and low aerobic capacity. PLoS ONE 2015;10:e0136150.
33. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011;12:R60.
34. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiol 1990;1:58-64.
35. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(4 Suppl):1220S-8S, discussion 1229S-1231S.
36. Qw Nava GM, Carbonero F, Croix JA, et al. Abundance and diversity of mucosa-Associated hydrogenotrophic microbes in the healthy human colon. ISME J 2012;6:57-70.
37. Schroeder BO, Wu Z, Nuding S, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011;469:419-23.
38. Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 2016;7:201-15.
39. Nakazawa F, Sato M, Poco SE, et al. Description of Mogibacterium pumilum gen. nov., sp. nov. and Mogibacterium vescum gen. nov., sp. nov., and reclassification of Eubacterium timidum (Holdeman et al. 1980) as Mogibacterium timidum gen. nov., comb. nov. Int J Syst Evol Microbiol 2000;50:679-88.
40. Thilesen CM, Nicolaidis M, Lökebö JE, et al. Leptotrichia amnionii, an emerging pathogen of the female urogenital tract. J Clin Microbiol 2007;45:2344-7.
41. Collins MD, Hoyles L, Tornqvist E, et al. Characterization of some strains from human clinical sources which resemble Leptotrichia sanguinegens: description of Sneathia sanguinegens sp. nov., gen. nov. Syst Appl Microbiol. 2001;24:358-61.
42. Griffen AL, Becker MR, Lyons SR, et al. Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol 1998;36:3239-42.
43. Flynn KJ, Baxter NT, Schloss PD. Metabolic and community synergy of oral bacteria in colorectal cancer. mSphere 2016;1:e00102-16.
44. Kaakoush NO. Insights into the Role of Erysipelotrichaceae in the human host. Front Cell Infect Microbiol 2015;5:84.
45. Lee JY, Arai H, Nakamura Y, et al. Contribution of the 7β-hydroxysteroid dehydrogenase from Ruminococcus gnavus N53 to ursodeoxycholic acid formation in the human colon. J Lipid Res 2013;54:3062-9.
46. Barrasa JI, Olmo N, Lizarbe MA, et al. Bile acids in the colon, from healthy to cytotoxic molecules. Toxicol In Vitro 2013;27:964-77.
47. Wei H, Dong L, Wang T, et al. Structural shifts of gut microbiota as surrogate endpoints for monitoring host health changes induced by carcinogen exposure. FEMS Microbiol Ecol 2010;73:577-86.
48. Bruinenberg PG, De Roo G, Limsowtin G. Purification and characterization of cystathionine (gamma)-lyase from lactococcus lactis subsp. cremoris SK11: possible role in flavor compound formation during cheese maturation. Appl Environ Microbiol 1997;63:561-6.
49. Persson S, Edlund MB, Claesson R, et al. The formation of hydrogen sulfide and methyl mercaptan by oral bacteria. Oral Microbiol Immun 1990; 5:195-201.
50. Göker M, Gronow S, Zeytun A, et al. Complete genome sequence of Odoribacter splanchnicus type strain (1651/6T). Stand Genomic Sci 2011;4:200-9.
51. Downes J, Vartoukian SR, Dewhirst FE, et al. Pyramidobacter piscolens gen. nov., sp. nov., a member of the phylum Synergistetes isolated from the human oral cavity. Int J Syst Evol Microbiol 2009;59:972-80.
52. Chan DS, Lau R, Aune D, et al. Red and processed meat and colorectal cancer incidence: meta-Analysis of prospective studies. PLoS ONE 2011;6:e20456.
53. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014;505:559-63.
54. Finegold SM, Vaisanen ML, Molitoris DR, et al. Cetobacterium somerae sp. nov. from human feces and emended description of the genus Cetobacterium. Syst Appl Microbiol 2003;26:177-81.
55. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012;487:104-8.
56. Willett WC, Stampfer MJ, Colditz GA, et al. Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med 1990;323:1664-72.
57. Fung TT, Hu FB, Wu K, et al. The mediterranean and dietary approaches to stop hypertension (DASH) diets and colorectal cancer. AmJClin Nutr 2010;92:1429-35.
58. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohns disease. Gastroenterology 2004;127:412-21.
59. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002;122:44-54.
60. Zoetendal EG, von Wright A, Vilpponen-Salmela T, et al. Mucosa-Associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol 2002;68:3401-7.
61. Tang MS, Poles J, Leung JM, et al. Inferred metagenomic comparison of mucosal and fecal microbiota from individuals undergoing routine screening colonoscopy reveals similar differences observed during active inflammation. Gut Microbes 2015;6:48-56.
62. Parthasarathy G, Chen J, Chen X, et al. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 2016;150:367-79.
63. Kipnis V, Midthune D, Freedman LS, et al. Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol 2001;153:394-403.
64. Subar AF, Freedman LS, Tooze JA, et al. Addressing current criticism regarding the value of self-report dietary data. J Nutr 2015;145:2639-45.